DPYD and colorectal carcinoma: As combination of 17-AAG with oxaliplatin and capecitabine has proved to have a higher impact on tumor inhibition17 , in this study, we aimed to investigate the effects of these combinations on DPD gene and protein expression levels in the panel of two CRC cell lines (HT-29&HCT-116).